Verywell Health on MSN

DMT Treatment Options for Multiple Sclerosis

In multiple sclerosis (MS), a person's immune system attacks the protective covering (myelin sheath) of nerve fibers in the ...
Medscape

Rituximab: More Effective Than Other Initial MS Treatments?

Anti-CD20 B cell-depleting agents such as rituximab may offer a promising initial disease-modifying treatment (DMT) for relapsing-remitting multiple sclerosis (RRMS) and primary progressive multiple ...
Medscape

Multiple Sclerosis Meds Significantly Underprescribed in Women

Women with multiple sclerosis (MS) are significantly less likely than men to be treated with disease-modifying therapies (DMTs) and highly effective DMTs (HE-DMTs), a new study showed. At comparable ...
MedPage Today

Deciding Whether Multiple Sclerosis Treatment Should Be Discontinued

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...
The American Journal of Managed Care

Emerging Strategies to Manage Pediatric-Onset Multiple Sclerosis

Pediatric-onset MS (POMS) is more inflammatory than adult-onset MS, with frequent relapses and cognitive issues, affecting 7.6% of MS cases. The 2017 McDonald criteria improved POMS diagnostic ...